Biotech Stocks

Here’s Why Tilray (TLRY) Stock Jumped 13% in After-Hours Trading

Shares of Tilray (TLRY) rallied in after-hours trading Tuesday, rising nearly 13%. Driving the medical cannabis maker’s stock was the news that the …

Here’s Why Biocept (BIOC) Stock Skyrocketed 80% Today

It’s a very rewarding trading day for investors in Biocept (BIOC) with shares up nearly 80%, making the stock Wall Street’s bull of …

Proteostasis Therapeutics (PTI) Sparks Optimism Among Investors; Here’s Why

Proteostasis Therapeutics (PTI) announced today a worldwide, exclusive license agreement with Genentech for the rights to a potential new therapy, without revealing what …

Tilray (TLRY) Prepares for Mass CBD Oil Purchase Following the Signing of Letter of Intent

The 2018 Farm Bill, which passed Congress is now headed to the desk of President Trump and if he signs it, hemp farms …

MYOS RENS Technology (MYOS) Stock Fires Up to the Roof; Here’s Why

MYOS RENS Technology (MYOS) stock is soaring — up over 50% since news broke today that The Vitamin Shoppe is picking up its product …

A Glimpse Into the Cannabis Stocks’ World

Investing in the marijuana industry may have seemed taboo a few years back, but as more states are making recreational marijuana legal with …

Cartel Investigation Drags Teva Pharmaceutical (TEVA) Stock Down; Evercore Weighs In

Israeli generic drug manufacturer Teva (TEVA) was named by the Washington Post as being one of more than a dozen subjects of a …

Marinus Pharmaceuticals (MRNS) Sparks Optimism Among Investors; Here’s Why

Marinus Pharmaceuticals (MRNS) just released positive results from its Phase 2 clinical trials, which evaluated ganaxolone intravenous (IV) (called the Magnolia Study) and …

Does Amarin’s (AMRN) Impending FDA Decision Matter?

Blogger Christiana Friedman says the FDA decision for Amarin’s (AMRN) drug Vascepa might not be the make or break for the company. In …

AcelRx (ACRX) Tumbles After Stock Offering Prices at Deep Discount

Shares of biotechnology company AcelRx (ACRX) are tumbling – down nearly 17% as of this writing. The reason?

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts